MENU
+Compare
ARWR
Stock ticker: NASDAQ
AS OF
Apr 24, 10:55 AM (EDT)
Price
$13.15
Change
+$0.14 (+1.08%)
Capitalization
1.7B

ARWR Arrowhead Pharmaceuticals Forecast, Technical & Fundamental Analysis

Arrowhead Pharmaceuticals Inc is an American biotechnology company... Show more

Industry: #Biotechnology
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ARWR with price predictions
Apr 23, 2025

ARWR in +7.70% Uptrend, growing for three consecutive days on April 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ARWR advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARWR's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on ARWR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARWR just turned positive on April 14, 2025. Looking at past instances where ARWR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

ARWR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARWR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARWR entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ARWR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (32.258) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (625.000) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARWR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARWR is expected to report earnings to fall 67.61% to -45 cents per share on May 08

Arrowhead Pharmaceuticals ARWR Stock Earnings Reports
Q1'25
Est.
$-0.45
Q4'24
Missed
by $1.00
Q3'24
Missed
by $0.39
Q2'24
Missed
by $0.85
Q1'24
Missed
by $0.55
The last earnings report on February 10 showed earnings per share of -138 cents, missing the estimate of -38 cents. With 31.93K shares outstanding, the current market capitalization sits at 1.70B.
A.I. Advisor
published General Information

General Information

a developer of novel drugs to treat intractable diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
177 E. Colorado Boulevard
Phone
+1 626 304-3400
Employees
525
Web
https://www.arrowheadpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBARX25.83N/A
N/A
Touchstone Balanced R6
HBGIX20.09N/A
N/A
Hartford Disciplined Equity HLS IB
TVRVX22.14N/A
N/A
Third Avenue Real Estate Value Investor
RGBBX36.11N/A
N/A
American Funds Global Balanced R2
MCSMX9.12N/A
N/A
Matthews China Small Companies

ARWR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+5.26%
DNLI - ARWR
56%
Loosely correlated
+1.85%
NTLA - ARWR
54%
Loosely correlated
-2.65%
RGNX - ARWR
53%
Loosely correlated
+13.43%
BEAM - ARWR
52%
Loosely correlated
+3.87%
VERV - ARWR
50%
Loosely correlated
+3.81%
More